Managing Earlier Integration of Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia |
0.75 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
Review of Oral Targeted Therapies in Acute Myeloid Leukemia |
0.75 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
Myelodysplastic Syndromes: Treatment Updates and Emerging Data |
0.50 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
Management of Multiple Myeloma: Smoldering, Newly Diagnosed, and Relapsed/Refractory Disease |
2.25 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
Managing Post-Treatment Complications for Multiple Myeloma and Acute Lymphocytic Leukemia |
1.00 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
Debate: Is the Addition of Polatuzumab Vedotin the New Standard First-Line Therapy for Diffuse Large B-Cell Lymphoma? |
0.75 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
Diffuse Large B-Cell Lymphoma: Sequencing Therapy for Relapsed/Refractory Disease |
0.50 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Updates in Prognosis and Treatment |
1.00 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
What is Optimal First-Line Management of Advanced Classic Hodgkin Lymphoma? |
0.75 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
NCCN Guidelines® Insights - Survivorship, Version 2.2024 |
1.00 |
12/10/2024 - 12:00am to 12/10/2025 - 12:00am |
Unraveling Cancer Pain Dynamics |
1.00 |
12/16/2024 - 12:00am to 10/31/2025 - 11:59pm |
Patient Management Simulator: Treatment Recommendations for Kidney Cancer with Management of Immunotherapy-Related Toxicities |
|
12/19/2024 - 12:00am to 12/19/2025 - 12:00am |
Vital Questions for Treatment of Bladder Cancer: Expert Insights on Recent and Near-Future Changes |
1.00 |
12/20/2024 - 12:00am to 12/20/2025 - 12:00am |
An Interactive Case-Based Review of Chronic Lymphocytic Leukemia: Experts Explore the Latest Evidence and Guideline Updates |
2.00 |
12/20/2024 - 12:00am to 12/20/2025 - 12:00am |
Recorded Presentation from the NCCN Pharmacy Updates: Advances in Neoadjuvant Treatment Options in Locally Advanced and Metastatic Rectal Cancer with... |
1.00 |
12/20/2024 - 12:00am to 12/20/2025 - 12:00am |